Candriam Luxembourg S.C.A. »

Janux Therapeutics shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.0M 80k 37.65

More positions owned by Candriam Luxembourg S.C.A.

Vipshop Hldgs Sponsored Ads A (Principal) (VIPS)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
Eli Lilly & Co. (LLY)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Visa Com Cl A (V)
Regeneron Pharmaceuticals (REGN)
Amgen (AMGN)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
salesforce (CRM)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Janux Therapeutics

RA Capital Management
FMR
OrbiMed Advisors
BVF
Adage Capital Partners GP
Citadel Advisors
Henderson Group
BlackRock
Vanguard Group
Cormorant Asset Management
Lord, Abbett & Co
Geode Capital Management
Avidity Partners Management
Goldman Sachs Group
Samlyn Capital

View all funds holding Janux Therapeutics